| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | Canada | 2 | |
| #3 | China | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies | |
| #6 | Analysing materials | |
| #7 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bonavia Aurelio M | 8 |
| #2 | Evans Thomas G | 8 |
| #3 | Anantha Ravi P | 8 |
| #4 | Picker Louis | 4 |
| #5 | Hansen Scott | 4 |
| #6 | Xu Guangwu | 4 |
| #7 | Laddy Dominick J | 4 |
| #8 | Tsao Eric I-Fu | 2 |
| #9 | Jin Tom Han | 2 |
| #10 | Velmurugan Kamalakannan | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2018016599A1 | Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis | |
| CN109890411A | Tuberculosis composition and treatment or prevention method lungy |